Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
China · Delayed Price · Currency is CNY 8.12
-0.18 (-2.17%)
Jun 18, 2026, 3:00 PM CST
SHA:603229 Market Cap
SHA:603229 has a market cap or net worth of 6.7 billion as of June 18, 2026. Its market cap has decreased by -3.25% in one year.
Market Cap
6.70B
Enterprise Value
6.03B
Revenue
794.80M
Ranking
n/a
PE Ratio
60.47
Stock Price
8.12
Market Cap Chart
Since May 9, 2017, SHA:603229's market cap has increased from 1.80B to 6.70B, an increase of 272.21%. That is a compound annual growth rate of 15.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 6.70B | -18.46% |
| Dec 31, 2025 | 8.22B | -0.94% |
| Dec 31, 2024 | 8.29B | 5.87% |
| Dec 29, 2023 | 7.83B | -18.09% |
| Dec 30, 2022 | 9.56B | -8.49% |
| Dec 31, 2021 | 10.45B | 19.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GemPharmatech | 7.82B |
| Daan Gene | 7.79B |
| Shanghai Medicilon | 7.50B |
| Sino Biological,Inc. | 7.37B |
| Bio-Thera Solutions | 7.06B |
| Beijing Hotgen Biotech | 6.82B |
| Acrobiosystems | 6.75B |
| Xiangxue Pharmaceutical | 6.55B |